Sales

In MedTech, Your Best Sales Asset Is Your Founder Story: How to Build It Like One

May 18, 20265 min readBy Vuelab

MedTech is the most product-focused industry I work in.

That’s not a criticism. It’s a function of the work. You spend years on the engineering, more years on the clinical pathway, and a generation of capital on getting the device to a point where it can be sold at all. By the time a founder is ready to commercialize, they know the product better than anyone in the room. The deck reflects it. The website reflects it. The sales motion reflects it.

The problem is that buyers don’t make decisions on product.

They make decisions on problems they’re trying to solve. And every meeting that opens with the device, the mechanism, the clearance, the differentiation grid, is asking the buyer to do the translation themselves. Most won’t. The ones who could become champions never get the language to advocate for you in the next meeting they’re in without you.

The shift that changes this isn’t a brand exercise. It’s a perspective shift: stop leading with the product, start leading with the story behind why you built it. Why this device, why this team, why now, and what problem you saw clearly enough to spend a decade fixing.

When MedTech companies make that shift, the sales motion gets easier. Cold conversations open faster because the problem is on the table before the device is. Warm conversations land harder because the technical detail has a reason to be there. Closing conversations move quicker because the buyer can already defend the purchase to their committee, they’ve internalized the why and they can repeat it.

The story isn’t decoration. It’s the most leveraged sales asset a MedTech company owns. And almost nobody treats it that way.

Why the story is an asset, not a vibe

When I tell MedTech founders their story is a sales asset, the response is usually a polite nod that means "I know, branding matters." That’s not what I mean.

A sales asset is something with measurable leverage across a sales cycle. A deck is an asset. A clinical study is an asset. A reference customer is an asset. The founder story belongs in that category, except most companies treat it as a one-time creative output (an "about us" page, a founder bio on the website) instead of as a controlled, distributed, maintained piece of sales infrastructure.

The companies that win the room in MedTech aren’t the ones with the densest spec sheet. They’re the ones whose story is consistent, sharp, and present at every stage of the cycle, the cold email, the discovery call, the second-meeting deck, the conference floor pitch, the rep’s first-week talk track, the founder’s standard podcast intro.

That doesn’t happen by accident. It happens because someone built it like an asset.

A repeatable method, not a creative exercise

Here’s the part most companies miss: building the founder story is a methodology, not a vibe. There’s an order to it. There’s craft to each step. The output isn’t a paragraph on the homepage, it’s a small, controlled set of canonical assets that get used across every channel a buyer will touch.

We use a seven-phase playbook for this work with our clients. I won’t run through it in full here, but it’s worth knowing the shape:

→ Phase 01, Prepare. Who runs the founder interview matters more than the questions. The wrong interviewer gets the rehearsed version of the story, which is the version that wasn’t working.

→ Phase 02, Interview. Four question arcs in a specific order: Origin, Conviction, Problem, Differentiation. Ninety minutes, recorded, no founder prep.

→ Phase 03, Mine. The transcript is the deliverable. The technique is reading it four times with four different filters and extracting the 8 to 12 lines that carry the weight. The first version of any line the founder says is almost always the real one.

→ Phase 04, Build. Four canonical assets get shaped from the raw material: a 30-second founder story, a problem statement (in three audience tunings), a differentiation paragraph, and a proof framing. These are the building blocks of everything downstream.

→ Phase 05, Map. The four assets aren’t used uniformly. Each does specific work at specific stages of the cycle, cold, warm, and proof. Mapping them is what turns the story into a sales operating system.

→ Phase 06, Design. The canon is text. Sales doesn’t happen in text. This is where the story becomes a designed asset stack, the deck, the mechanism-of-action animation, the sales sheets, the founder story video. The discipline is that design serves the canon, not the other way around.

→ Phase 07, Distribute. A canon in a Notion page is worth almost nothing. The canon compounds when every sales surface pulls from the same controlled source and updates the moment anything changes.

That’s the shape. The full method, every question, every reading pass, a worked example with the four canonical assets built out, is on the Vuelab playbook page. It’s open. No gate.

The shift that makes the rest of it work

If you take only one thing from this, take this: the move from product-focused to story-focused isn’t a marketing decision. It’s a strategic decision about what your company is actually selling.

You’re not selling a device. You’re selling the resolution of a problem the buyer is already feeling. The device is the mechanism by which that resolution happens. The story is what makes the buyer believe the resolution is real, defensible, and worth saying yes to.

The technology still has to be there. The clinical evidence still has to be there. The regulatory path still has to be there. None of that is optional in MedTech. But none of those things is the reason a buyer says yes. They’re the reasons the buyer can defend saying yes to everyone they need to defend it to.

The reason they say yes is the story.

Lead with the technology and you’re selling a tool.

Lead with the story and you’re selling a reason.

If you want the full method, interview questions, transcript-mining technique, worked example, cycle map, we put the whole playbook here: vuelab.com/playbook. Open, no gate, designed to be useful whether you run it yourself or bring in help.

FAQs

Frequently asked questions.

What’s the difference between a brand story and a sales asset?

A brand story is the polished narrative a company puts on its homepage, mission, vision, values. It’s a creative output, usually written once and updated occasionally. A sales asset is something with measurable leverage across a sales cycle, controlled, distributed, and maintained. The founder story belongs in the second category. Most companies treat it like the first, which is why it doesn’t compound.

Why does founder-led storytelling work better in MedTech than in other industries?

MedTech buyers, clinicians, administrators, procurement committees, are professionally risk-averse. They have to defend their decisions to peers, hospitals, and sometimes patients. In that environment, the founder story does work no other content can: it signals conviction. It tells the buyer that the people behind the device aren’t tourists in the category. That signal matters more in MedTech than in most other industries because the cost of a bad purchase is higher and the room is more skeptical.

Does this work if the founder isn’t a natural storyteller?

Most founders aren’t natural storytellers because they’re too close to the product. The fix isn’t training the founder to be a better storyteller, it’s running a structured interview process that extracts the story from them in their own words. The raw material is almost always there. It just needs to be surfaced, sharpened, and shaped into canonical assets the rest of the team can use.

What’s the difference between a story-first approach and just having good marketing?

Marketing is downstream. A story-first approach is upstream: it determines what marketing, sales, and even product positioning are built on top of. Good marketing without a controlled story produces a polished surface that doesn’t compound. A controlled story without good marketing still produces sales leverage because every rep, every channel, and every founder appearance is pulling from the same source.

How long does it take to build a founder story like an asset?

The interview, transcript mining, and canon-building portion takes about a week of focused work. Designing the canon into a full asset stack, deck, animation, sales sheets, web, video, takes another four to eight weeks. Distribution and maintenance is ongoing. The whole process is detailed in the Vuelab playbook, including the questions, the technique, and a worked example.

Launching a product?
Let’s make it unmissable.

Give us a few minutes, and we’ll show you how to better visualize your product.